The present invention relates to a process for formulating acid stabilized oral bacterial vaccine, more particularly a combination of whole cell inactivated bacteria and acid stabilized rCTB (recombinant cholera toxin B) resulting in synergistic protection against diarrhea caused by various bacteria such as Vibrio cholerae, Enterotoxigenic Escherichia coli (ETEC).